Search
See the whole debate « Previous speaker Next speaker »
Mr. Oliver O'Connor:
IP rights apply to all levels of the discovery, from small biotech companies up to mid-sized and larger companies. The TRIPS waiver is a change of rules that will have an effect.
Add your comment
